| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Mar―03 |
Parents' habits of using food supplements for their children: The impact of the COVID-19 pandemic process use of nutritional supplements in children during COVID-19 |
Derya Doğanay, Müzeyyen Aydin, Nurcihan Aslan, İrem Çelik, Ahmet Doğanay, Yusuf Çelik |
| 2 |
[GO] |
2024―Aug―01 |
Assessing Thromboembolic Complications and In- Hospital Mortality and Clinical Factors Affecting Thromboembolic Complications in COVID-19 stage 3-5 ICU cases |
Wan Nur Maisarah Wan Rosli, Tharmini Ravi, Long Chiau Ming, Hanis Hanum Zulkifly |
| 3 |
[GO] |
2024―Feb―09 |
Preferred medicinal plants during the COVID-19 pandemic period: Microbiological quality of herbal teas obtained from these plants |
Derya DOĞANAY, Büşra KULAKSIZ PİŞKİN, Müzeyyen AYDIN, Begüm KAPLAN |
| 4 |
[GO] |
2024―Jan―30 |
STUDY OF THE IMMUNOGENICITY OF COMBINATION OF RECOMBINANT RBD (OMICRON) AND NUCLEOCAPSID PROTEINS OF SARS-COV-2 EXPRESSED IN PICHIA PASTORIS |
Shakhnoz AZIMOVA, Sobirdjan SASMAKOV, Farkhod ESHBOEV, Jaloliddin ABDURAKHMANOV, Oybek ASHIROV, Shukhrat KHASANOV, et al. (+5) Artyom MAKHNYOV, Orzigul ALIMUKHAMEDOVA, Elvira YUSUPOVA, Galina PIYAKINA, Saidazim IKRAMOV |
| 5 |
[GO] |
2023―Dec―08 |
COVID-19 vaccine-related pathologies: cardiac and neurological side effects and Long-term COVID-19 |
Beril ANILANMERT, Fatma CAVUS YONAR, Gulten RAYIMOGLU |
| 6 |
[GO] |
2023―Jul―17 |
Public knowledge and attitude towards medications and dietary supplements used during COVID-19 self-isolation: a cross sectional survey in Surabaya, Indonesia |
Ilil Maidatuz ZULFA, Silfiana Nisa PERMATASARI |
| 7 |
[GO] |
2023―Mar―13 |
Self-medication Practices for COVID-19 Prevention: A Study among Medical Students in Yogyakarta, Indonesia |
Putri Salisa MAULIDA, Riana RAHMAWATI |
| 8 |
[GO] |
2023―Jan―31 |
In silico evaluation of potential murine M49 DNA aptamer on ORF7a of SARS-COV-2: A similar target |
Nor Azlina AHMAD, Razauden Mohamed ZULKIFLI, Huszalina HUSSIN, Syazwani Itri AMRAN, Muhammad Helmi NADRI, Saiful Izwan ABDUL RAZAK, et al. (+2) Sabrinah ADAM, Farahwahida MOHD YUSOF |
| 9 |
[GO] |
2022―Nov―18 |
Pharmaceutical, biological agents, and vaccines under clinical trials for COVID-19 and roles of pharmacists to combat COVID-19, an update |
Mari Kannan MAHARAJAN, Kingston RAJIAH, Bharath POGULA, Sridevi CHIGURUPATI, Sujitha KATRAGADDA |
| 10 |
[GO] |
2022―Nov―18 |
Basic good manufacturing practices (GMP), special conditions and inspection processes in the Covid19 (SARS-CoV-2) pandemic |
Abdullah Levent ALPARSLAN |
| 11 |
[GO] |
2022―Sep―09 |
DNA intercalators alkaloids as Potential candidates to fight COVID-19 disease: Systematic review |
Houria BECHLEM, Feryal BENAYACHE, Djamila BENOUCHENNE, Amira LABED |
| 12 |
[GO] |
2021―Nov―25 |
Aminophylline as anti-hypoxic add-on therapy in the management of COVID-19 in Baghdad: An experience from single center report case study |
Jamal Mawlood KHALAF, Ismail Ibrahim HUSSEIN, Marwan Salih ALNIMER |
| 13 |
[GO] |
2021―Nov―25 |
Assessment of some prescribed drugs in the management of COVID-19 on the survival function: A preliminary report from a single center in Iraq |
Marwan Salih ALNIMER, Talar Ahmad MERZA |
| 14 |
[GO] |
2021―Nov―25 |
A new frontier: Navigating hospital pharmacy practice during the COVID-19 pandemic |
Nora BAIRAGDAR, Abigail Dee ANTIGUA, Mohammed ALSAID |
| 15 |
[GO] |
2021―Nov―25 |
Novel and promising approaches in COVID-19 treatment |
Zahra ASEFY, Hamid RASHIDZADEH, Ali MOHAMMADI, Mohammad CHAREHSAZ |
| 16 |
[GO] |
2021―Nov―25 |
Socio-demographic determinants of beliefs about COVID-19 vaccine in Nigeria |
Chinonyerem Ogadi IHEANACHO, Okechukwu Harrison ENECHUKWU, Chinelo Nneka AGUIYIIKEANYI |
| 17 |
[GO] |
2021―Nov―23 |
Administration of systemic steroids during hospitalization does not improve the clinical outcome in patients with Covid-19 |
Ranjit BANWAIT, Sad ALQUADAN, Sarah WILSON, Dhaval UPADHYAY, Devina SINGH |
| 18 |
[GO] |
2021―Nov―23 |
Knowledge and attitudes of community pharmacists about COVID-19 |
Nilay AKSOY, Öyküm DEMİREL |
| 19 |
[GO] |
2021―Nov―23 |
Knowledge and attitudes of pharmacy students about COVID-19 |
Emre KARA, Nesligül ÖZDEMİR, Gülçin Telli DİZMAN, Kutay DEMİRKAN, Serhat ÜNAL |
| 20 |
[GO] |
2021―Nov―23 |
An evaluation of public understanding regarding COVID-19 in Sindh, Pakistan: A focus on knowledge, attitudes and practices |
Narendar KUMAR, Syed Azhar Syed SULAIMAN, Furqan Khurshid HASHMI |
| 21 |
[GO] |
2021―Nov―23 |
A cross-sectional survey of herbal remedy taking to prevent Covid-19 in Turkey |
Zeynep Büşra ERARSLAN, Şükran KÜLTÜR |
| 22 |
[GO] |
2021―Nov―23 |
Hematological and inflammatory parameters in hospitalized patients with COVID-19 infection in Chattogram, Bangladesh |
Md. Rakibul Hassan BULBUL, Md. Giash UDDIN, Kazi Ishrak FAIYAZ, Mohammad Rashedul ISLAM, Md. Ashraful ALAM |
| 23 |
[GO] |
2021―Nov―23 |
Investigation of the usage of herbal products during the Covid-19 pandemic |
Semih BULUT, Burcu ÖZTÜRK ŞAHİN, Nilgün YILMAZ DEMİRCİ, Didem DELİORMAN ORHAN |
| 24 |
[GO] |
2021―Nov―23 |
COVID-19 pandemic and the healthcare workers- The call of duty |
Shaib MUHAMMAD, Geeta KUMAR, Narendar KUMAR, Rafia TABASSUM |
| 25 |
[GO] |
2021―Nov―23 |
The role of community pharmacists during the COVID-19 pandemic in the U.S. |
Mehmed Bulend UGUR, Irem Tutku ASLANBAY, Zeynep Sena MUS |
| 26 |
[GO] |
2021―Nov―23 |
Dendritic cell-based COVID-19 vaccines: A mini review |
Dewi PERTIWI, hsanul HAFIZ, Didi Nurhadi ILLIAN |
| 27 |
[GO] |
2021―Nov―23 |
Bioflavonoids as potential target inhibitors in COVID-19: An in silico analysis |
Uma Sankar GORLA, Koteswara Rao GSN, Umasankar KULANDAIVELU |
| 28 |
[GO] |
2021―Nov―23 |
Community pharmacy practice and challenges amid the coronavirus disease-19 pandemic: A survey in southwest Ethiopia |
Behailu TEREFE, Mengist AWOKE, Dula DESSALEGN, Girma MAMO, Bezie KEBEDE, Temesgen MULUGETA |
| 29 |
[GO] |
2021―Nov―23 |
Evaluation of molnupiravir analogues as novel coronavirus (SARS CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study |
Necla KULABAŞ, Tuğçe YEŞİL, İlkay KÜÇÜKGÜZEL |
| 30 |
[GO] |
2021―Nov―23 |
Molecular docking, molecular dynamic and drug-likeness studies of natural flavonoids as inhibitors for SARS-CoV-2 main protease (Mpro) |
Listiana OKTAVIA, Praptiwi PRAPTIWI, Andria AGUSTA |
| 31 |
[GO] |
2021―Nov―23 |
Pyrazine-chromene-3-carbohydrazide conjugates: Molecular docking and ADMET predictions on dual-acting compounds against SARS-CoV-2 Mpro and RdRp |
Arif MERMER, Serhii VAKAL |
| 32 |
[GO] |
2021―Nov―23 |
Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes |
Ahmet Fatih Şahin, Ş. Güniz KÜÇÜKGÜZEL, Atilla Akdemir |
| 33 |
[GO] |
2021―Nov―20 |
COVID-19 and the role of e-cigarette use: An evidence-based review |
İsmet ÇOK, İrem İYİGÜNDOĞDU, Mesut YILDIRIM |
| 34 |
[GO] |
2021―Nov―20 |
A recent update of anticoagulant therapy on severe COVID-19 patients |
Taofik RUSDIANA, Norisca Aliza PUTRIANA, Patihul HUSNI |
| 35 |
[GO] |
2021―Nov―19 |
Association between COVID-19 and psychological disorders with possible mechanisms |
Sworadip CHOWDHURY, Hoimonti DEBI, Mohammad Tohidul AMIN, Sujan BANIK |
| 36 |
[GO] |
2021―Nov―19 |
Effects of the Covid-19 pandemic on brain and behavior |
Tayfun UZBAY |
| 37 |
[GO] |
2020―Sep―14 |
What we know about COVID-19 and its treatment |
Zatiye Ayça ÇEVİKELLİ YAKUT, Sinem ŞAKARCAN, Göksel ŞENER |
